Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory

Journal of Clinical Microbiology

Volumn 39, Issue 6, 2001, Pages 2206-2212

  Paterson, D L ^a   Ko, W C ^a   Von Gottberg, A ^a   Casellas, J M ^a   Mulazimoglu, L ^a   Klugman, K P ^a   Bonomo, R A ^a   Rice, L B ^a   McCormack, J G ^a   Yu, V L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; GENTAMICIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BETA-LACTAMASES; CEPHALOSPORINS; CHILD; FEMALE; GENOTYPE; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TREATMENT OUTCOME;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 0035003640     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.6.2206-2212.2001     Document Type: Article

References (28)

1. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998
2. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
3. Laboratory capacity to detect antimicrobial resistance, 1998
4. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center
5. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like β-lactamase
6. CDC definitions for nosocomial infections
7. Detection of extended-spectrum betalactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
8. Treatment failure due to extended spectrum β-lactamase
9. Relationship between indole production and the differentiation of Klebsiella species: Indole-positive and -negative isolates of Klebsiella determined to be clonal
10. Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: Effect of large inocula
11. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
12. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
13. Performance standards for antimicrobial disk susceptibility tests
14. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients
15. In vivo selection of a cephamycin-resistant porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase
16. Extended-spectrum beta-lactamases: A call for improved detection and control
17. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
18. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
19. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility
20. Efficacy of different β-lactams against an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model
21. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation
22. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes
23. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum β-lactamase
24. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
25. Detection and reporting of organisms producing extended-spectrum beta-lactamases: Survey of laboratories in Connecticut
26. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum β-lactamase-producing strain of Klebsiella pneumoniae
27. Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamases
28. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit